Allergy Therapeutics (Allergy Therapeutics) Issuance of Stock

: $50.29 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

Allergy Therapeutics's Issuance of Stock for the six months ended in Dec. 2023 was $50.29 Mil.

Allergy Therapeutics's Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2023 was $50.29 Mil.

Allergy Therapeutics Issuance of Stock Historical Data

The historical data trend for Allergy Therapeutics's Issuance of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Issuance of Stock

Get a 7-Day Free Trial

13.44

0.01

8.19

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Issuance of Stock	Get a 7-Day Free Trial															-	-	7.90	-	50.29

Allergy Therapeutics Issuance of Stock Calculation

A company may raise cash from issuing new shares. Issuance of Stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Issuance of Stock for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $50.29 Mil.

Allergy Therapeutics Issuance of Stock Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Issuance of Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Allergy Therapeutics (Allergy Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (OTCPK:AGYTF) » Definitions » Issuance of Stock

Comparable Companies

Traded in Other Exchanges

AGY:UK HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.